12/20/2011

European regulators have granted Sphere Medical CE Mark approval for its Proxima Generation 2 device as an in vitro diagnostic tool. The approval comes after it was reported last month that the device proved to be as effective as point-of-care and laboratory blood gas analyzers in tracking arterial blood in a clinical environment.

Full Story:
Reuters

Related Summaries